Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersPaolo Peterlongo, Javier Benı́tez, Laura Matricardi et al.|Cancer Epidemiology Biomarkers & Prevention|2014Cited by 25
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancerAntoinette Hollestelle, Saundra S. Buys, Frederieke H. van der Baan et al.|Gynecologic Oncology|2015Cited by 20
Supplementary Table 3 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersPaolo Peterlongo, Javier Benı́tez, Jenny Chang‐Claude et al.|Unknown|2023Cited by 0
Supplementary Table 2 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersPaolo Peterlongo, Javier Benı́tez, Jenny Chang‐Claude et al.|Unknown|2023Cited by 0
Supplementary Table 2 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersPaolo Peterlongo, Javier Benı́tez, Jenny Chang‐Claude et al.|Unknown|2023Cited by 0